Adaptation of Impression Cytology to Enable Conjunctival Surface Cell Transcriptome Analysis
暂无分享,去创建一个
[1] Gerd Geerling,et al. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications , 2014, Acta ophthalmologica.
[2] M. Beasley,et al. Comparison of low-abundance biomarker levels in capillary-collected nonstimulated tears and washout tears of aqueous-deficient and normal patients. , 2013, Investigative ophthalmology & visual science.
[3] F. Takeuchi,et al. The genetic contribution of HLA‐DRB5*01:01 to systemic lupus erythematosus in Thailand , 2013, International journal of immunogenetics.
[4] H. Yamanaka,et al. Up-regulated expression of HLA-DRB5 transcripts and high frequency of the HLA-DRB5*01:05 allele in scleroderma patients with interstitial lung disease. , 2012, Rheumatology.
[5] L. Módis,et al. Evaluation of Tear Osmolarity in Non-Sjögren and Sjögren Syndrome Dry Eye Patients With the TearLab System , 2012, Cornea.
[6] S. Bowman,et al. Biologic therapies in primary Sjögren's syndrome. , 2012, Current pharmaceutical biotechnology.
[7] Toshiharu Hayashi. Dysfunction of Lacrimal and Salivary Glands in Sjögren's Syndrome: Nonimmunologic Injury in Preinflammatory Phase and Mouse Model , 2011, Journal of biomedicine & biotechnology.
[8] Gerd Geerling,et al. An objective approach to dry eye disease severity. , 2010, Investigative ophthalmology & visual science.
[9] J. Daniels,et al. Clinical Trials of Therapeutic Ocular Surface Medium for Moderate to Severe Dry Eye , 2010, Cornea.
[10] E. Campos,et al. Tear proteomics in evaporative dry eye disease , 2010, Eye.
[11] M. Burton,et al. Conjunctival expression of matrix metalloproteinase and proinflammatory cytokine genes after trichiasis surgery. , 2010, Investigative ophthalmology & visual science.
[12] J. Gu,et al. Prostate Stem Cell Antigen: A Jekyll and Hyde Molecule? , 2010, Clinical Cancer Research.
[13] B. Bucheton,et al. IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani. , 2009, The Journal of clinical investigation.
[14] Johnny L Gayton,et al. etiology , prevalence , and treatment of dry eye disease , 2009 .
[15] M. Senchyna,et al. Tear Lipocalin and Lysozyme in Sjögren and Non-Sjogren Dry Eye , 2008, Optometry and vision science : official publication of the American Academy of Optometry.
[16] L. Donnelly,et al. Th17 cells in airway diseases. , 2008, Current molecular medicine.
[17] M. Malmsten,et al. The Human CXC Chemokine Granulocyte Chemotactic Protein 2 (GCP-2)/CXCL6 Possesses Membrane-Disrupting Properties and Is Antibacterial , 2008, Antimicrobial Agents and Chemotherapy.
[18] Stefano Barabino,et al. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. , 2008, Archives of ophthalmology.
[19] R. Fullard,et al. Multiple Cytokine Analysis in Human Tears: An Optimized Procedure for Cytometric Bead-Based Assay , 2008, Current eye research.
[20] D. Korb,et al. An Evaluation of the Efficacy of Fluorescein, Rose Bengal, Lissamine Green, and a New Dye Mixture for Ocular Surface Staining , 2008, Eye & contact lens.
[21] Christophe Baudouin,et al. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). , 2007, The ocular surface.
[22] N. Ishimaru,et al. Analysis of in Vivo Role of α-Fodrin Autoantigen in Primary Sjögren’s Syndrome , 2005 .
[23] R. Hipskind,et al. Down-Regulation of c-Fos/c-Jun AP-1 Dimer Activity by Sumoylation , 2005, Molecular and Cellular Biology.
[24] H. Friess,et al. Prostate Stem Cell Antigen Is a Putative Target for Immunotherapy in Pancreatic Cancer , 2005, Pancreas.
[25] M. Zatz,et al. Calpains and disease. , 2005, The New England journal of medicine.
[26] T. Fujimori,et al. TSC-22 (TGF-beta stimulated clone-22): a novel molecular target for differentiation-inducing therapy in salivary gland cancer. , 2004, Current cancer drug targets.
[27] Zhao Zhigang,et al. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer. , 2004, Japanese journal of clinical oncology.
[28] K. Okubo,et al. Up-regulated gene expression in the conjunctival epithelium of patients with Sjögren's syndrome. , 2003, Experimental eye research.
[29] F. Speleman,et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.
[30] R. Jonsson,et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.
[31] B. Nakken,et al. Associations of MHC Class II Alleles in Norwegian Primary Sjögren's Syndrome Patients: Implications for Development of Autoantibodies to the Ro52 Autoantigen , 2001, Scandinavian journal of immunology.
[32] S. Pflugfelder,et al. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. , 1999, Current eye research.
[33] G. Foulks,et al. Evaluation of the effect of lissamine green and rose bengal on human corneal epithelial cells. , 1999, Cornea.
[34] P Cho,et al. Schirmer test. I. A review. , 1993, Optometry and vision science : official publication of the American Academy of Optometry.
[35] Francis Heed Adler,et al. Adler's Physiology of the eye;: Clinical application , 1976 .
[36] N. Ishimaru,et al. Analysis of in vivo role of alpha-fodrin autoantigen in primary Sjogren's syndrome. , 2005, The American journal of pathology.